Pharmaceutical Analysis Laboratory

Lab Overview

The Pharmaceutical Analysis Laboratory is a high-throughput analytical environment supporting chemical and pharmaceutical analysis, method development, impurity profiling, stability testing, and quality-oriented education. Its mission is to train students and support researchers in the analytical disciplines that underpin pharmaceutical quality, regulatory confidence, and product safety.

The laboratory provides access to chromatography, detector-based molecular analysis, volatile compound analysis, and sample preparation workflows. Students engage with analytical method validation, quantification of active pharmaceutical ingredients, stability assessment, impurity detection, and the interpretation of complex molecular mixtures. This creates a direct connection between academic training and the operational realities of pharmaceutical quality assurance and quality control.

For UNIC Nicosia, the laboratory is strategically important because analytical capability is central to pharmaceutical development, regulatory science, manufacturing, clinical research, and translational innovation. It provides a platform for collaboration with industry, contract research partners, academic researchers, and quality-focused organisations.

Research & Innovation Focus

The laboratory enables research and teaching innovation in analytical method development, pharmaceutical quantification, impurity and degradation profiling, stability studies, volatile compound analysis, and regulatory-oriented analytical training. Students learn not only to operate instrumentation, but to understand selectivity, sensitivity, reproducibility, validation parameters, and data integrity.

The presence of HPLC systems with PDA and QDa mass detection, together with GC-FID and GC-TCD capabilities, allows the laboratory to support a range of chemical and pharmaceutical workflows. Freeze-drying capacity further strengthens sample preparation for thermolabile compounds and complex matrices.

Core Capabilities

The laboratory enables:

• HPLC-based pharmaceutical analysis using PDA and QDa mass detection.
• Molecular weight confirmation and separation of complex pharmaceutical mixtures.
• GC-FID and GC-TCD analysis of volatile compounds.
• Quantification of active pharmaceutical ingredients in formulations and selected matrices.
• Impurity profiling, degradation assessment, and stability-oriented workflows.
• Analytical method development and validation training aligned with international quality expectations.
• Freeze-drying and vacuum-supported sample preparation for sensitive materials.
• Support for QA/QC education, final-year projects, and faculty research.

Collaboration Opportunities

The Pharmaceutical Analysis Laboratory is positioned for collaboration with pharmaceutical companies, CROs, QC laboratories, regulatory science groups, formulation developers, EU research projects, and academic partners requiring robust analytical support. It can contribute to method-development studies, stability testing, impurity profiling, training programmes, analytical feasibility assessments, and student-industry research projects.

Its strategic value is strongest where high-quality analytical evidence is required to support pharmaceutical development, product evaluation, and translational decision-making.